Skip to main content
SpringerLink
Log in
Book cover

Cytokines and Cancer pp 103–127Cite as

Pro-apototic and Anti-apoptotic Effects of Tumor Necrosis Factor in Tumor Cells

Role of Nuclear Transcription Factor NF-κB

  • Chapter

Part of the book series: Cancer Treatment and Research ((CTAR,volume 126))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Jacobson M. D., Weil M., Raff M. C.: Programmed cell death in animal development. Cell. 88:347–354, 1997

    Article  PubMed  CAS  Google Scholar 

  2. Darmon A. J., Nicholson D. W., Bleackley R. C.: Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature. 377:446–448, 1995

    Article  PubMed  CAS  Google Scholar 

  3. Shibata S., Kyuwa S., Lee S. K., Toyoda Y., Goto N.: Apoptosis induced in mouse hepatitis virus-infected cells by a virus-specific CD8+ cytotoxic T-lymphocyte clone. J Virol. 68:7540–7545, 1994

    PubMed  CAS  Google Scholar 

  4. Jaattela M.: Escaping cell death: survival proteins in cancer. Exp Cell Res. 248:30–43, 1999

    Article  PubMed  CAS  Google Scholar 

  5. Stambolic V., Mak T. W., Woodgett J. R.: Modulation of cellular apoptotic potential: contributions to oncogenesis. Oncogene. 18:6094–6103, 1999

    Article  PubMed  CAS  Google Scholar 

  6. Nagata S.: Apoptosis by death factor. Cell. 88:355–365, 1997

    Article  PubMed  CAS  Google Scholar 

  7. Aggarwal B. B., Vilcek J. Tumore Necrosis Factor: Structure, Function and Mechanism of Action. New York: Marcel Dekker; 1992

    Google Scholar 

  8. Ghosh S., May M. J., Kopp E. B.: NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 16:225–260, 1998

    Article  PubMed  CAS  Google Scholar 

  9. Beg A. A., Baldwin A. S., Jr.: The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev. 7:2064–2070, 1993

    PubMed  CAS  Google Scholar 

  10. Karin M.: How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene. 18:6867–6874, 1999

    Article  PubMed  CAS  Google Scholar 

  11. Pahl H. L.: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 18:6853–6866, 1999

    Article  PubMed  CAS  Google Scholar 

  12. Chen F. E., Ghosh G.: Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views. Oncogene. 18:6845–6852, 1999

    Article  PubMed  CAS  Google Scholar 

  13. Arends M. J., Wyllie A. H.: Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol. 32:223–254, 1991

    PubMed  CAS  Google Scholar 

  14. Kerr J. F., Wyllie A. H., Currie A. R.: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:239–257, 1972

    PubMed  CAS  Google Scholar 

  15. Clarke P. G., Clarke S.: Historic apoptosis. Nature. 378:230, 1995

    Article  PubMed  CAS  Google Scholar 

  16. Cohen J. J.: Apoptosis. Immunol Today. 14:126–130, 1993

    Article  PubMed  CAS  Google Scholar 

  17. Chinnaiyan A. M., Dixit V. M.: The cell-death machine. Curr Biol. 6:555–562, 1996

    Article  PubMed  CAS  Google Scholar 

  18. McDonnell T. J., Korsmeyer S. J.: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature. 349:254–256, 1991

    Article  PubMed  CAS  Google Scholar 

  19. Thompson C. B.: Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456–1462, 1995

    PubMed  CAS  Google Scholar 

  20. Gilmore T. D., Koedood M., Piffat K. A., White D. W.: Rel/NF-kappaB/IkappaB proteins and cancer. Oncogene. 13:1367–1378, 1996

    PubMed  CAS  Google Scholar 

  21. Cohen G. M.: Caspases: the executioners of apoptosis. Biochem J. 326 ( Pt 1):1–16, 1997

    PubMed  CAS  Google Scholar 

  22. Green D. R.: Apoptotic pathways: paper wraps stone blunts scissors. Cell. 102:1–4, 2000

    Article  PubMed  CAS  Google Scholar 

  23. Bhardwaj A, Aggarwal BB. Receptor-mediated choreography of life and death. J Clin Immunol. 23:317–32, 2003.

    Article  PubMed  CAS  Google Scholar 

  24. Cerretti D. P., Kozlosky C. J., Mosley B., Nelson N., Van Ness K., Greenstreet T. A., March C. J., Kronheim S. R., Druck T., Cannizzaro L. A., et al.: Molecular cloning of the interleukin-1 beta converting enzyme. Science. 256:97–100, 1992

    PubMed  CAS  Google Scholar 

  25. Kaufmann S. H.: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49:5870–5878, 1989

    PubMed  CAS  Google Scholar 

  26. Kaufmann S. H., Desnoyers S., Ottaviano Y., Davidson N. E., Poirier G. G.: Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53:3976–3985, 1993

    PubMed  CAS  Google Scholar 

  27. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S.: A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:43–50, 1998

    Article  PubMed  CAS  Google Scholar 

  28. Song Q., Lees-Miller S. P., Kumar S., Zhang Z., Chan D. W., Smith G. C., Jackson S. P., Alnemri E. S., Litwack G., Khanna K. K., Lavin M. F.: DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. Embo J. 15:3238–3246, 1996

    PubMed  CAS  Google Scholar 

  29. Takahashi A., Alnemri E. S., Lazebnik Y. A., Fernandes-Alnemri T., Litwack G., Moir R. D., Goldman R. D., Poirier G. G., Kaufmann S. H., Earnshaw W. C.: Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci USA. 93:8395–8400, 1996

    Article  PubMed  CAS  Google Scholar 

  30. Martin S. J., O'Brien G. A., Nishioka W. K., McGahon A. J., Mahboubi A., Saido T. C., Green D. R.: Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem. 270:6425–6428, 1995

    Article  PubMed  CAS  Google Scholar 

  31. Brancolini C., Benedetti M., Schneider C.: Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE-like proteases. Embo J. 14:5179–5190, 1995

    PubMed  CAS  Google Scholar 

  32. Mashima T., Naito M., Fujita N., Noguchi K., Tsuruo T.: Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem Biophys Res Commun. 217:1185–1192, 1995

    Article  PubMed  CAS  Google Scholar 

  33. Casciola-Rosen L., Nicholson D. W., Chong T., Rowan K. R., Thornberry N. A., Miller D. K., Rosen A.: Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med. 183:1957–1964, 1996

    Article  PubMed  CAS  Google Scholar 

  34. Antoku K., Liu Z., Johnson D. E.: Inhibition of caspase proteases by CrmA enhances the resistance of human leukemic cells to multiple chemotherapeutic agents. Leukemia. 11:1665–1672, 1997

    Article  PubMed  CAS  Google Scholar 

  35. Widmann C., Gibson S., Johnson G. L.: Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem. 273:7141–7147, 1998

    Article  PubMed  CAS  Google Scholar 

  36. Green D. R., Reed J. C.: Mitochondria and apoptosis. Science. 281:1309–1312, 1998

    Article  PubMed  CAS  Google Scholar 

  37. Susin S. A., Zamzami N., Kroemer G.: Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta. 1366:151–165, 1998

    Article  PubMed  CAS  Google Scholar 

  38. Adams J. M., Cory S.: The Bcl-2 protein family: arbiters of cell survival. Science. 281:1322–1326, 1998

    Article  PubMed  CAS  Google Scholar 

  39. Gross A., McDonnell J. M., Korsmeyer S. J.: BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1899–1911, 1999

    PubMed  CAS  Google Scholar 

  40. Weldon C. B., Burow M. E., Rolfe K. W., Clayton J. L., Jaffe B. M., Beckman B. S.: NF-kappa B-mediated chemoresistance in breast cancer cells. Surgery. 130:143–150, 2001

    Article  PubMed  CAS  Google Scholar 

  41. Sheikh M. S., Fornace A. J., Jr.: Death and decoy receptors and p53-mediated apoptosis. Leukemia. 14:1509–1513, 2000

    Article  PubMed  CAS  Google Scholar 

  42. Ashkenazi A., Dixit V. M.: Death receptors: signaling and modulation. Science. 281:1305–1308, 1998

    Article  PubMed  CAS  Google Scholar 

  43. Smith C. A., Farrah T., Goodwin R. G.: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 76:959–962, 1994

    Article  PubMed  CAS  Google Scholar 

  44. Mukhopadhyay A., Ni J., Zhai Y., Yu G. L., Aggarwal B. B.: Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J Biol Chem. 274:15978–15981, 1999

    Article  PubMed  CAS  Google Scholar 

  45. Haridas V., Shrivastava A., Su J., Yu G. L., Ni J., Liu D., Chen S. F., Ni Y., Ruben S. M., Gentz R., Aggarwal B. B.: VEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth. Oncozene. 18:6496–6504, 1999

    Article  CAS  Google Scholar 

  46. Rath P. C., Aggarwal B. B.: TNF-induced signaling in apoptosis. J Clin Immunol. 19:350–364, 1999

    Article  PubMed  CAS  Google Scholar 

  47. Darnay B. G., Aggarwal B. B.: Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors. Ann Rheum Dis. 58Suppl 1:I2–I13, 1999

    Article  PubMed  CAS  Google Scholar 

  48. Wallach D., Varfolomeev E. E., Malinin N. L., Goltsev Y. V., Kovalenko A. V., Boldin M. P.: Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol. 17:331–367, 1999

    Article  PubMed  CAS  Google Scholar 

  49. Beg A. A., Baltimore D.: An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 274:782–784, 1996

    Article  PubMed  CAS  Google Scholar 

  50. Liu Z. G., Hsu H., Goeddel D. V., Karin M.: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell. 87:565–576, 1996

    Article  PubMed  CAS  Google Scholar 

  51. Van Antwerp D. J., Martin S. J., Kafri T., Green D. R., Verma I. M.: Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science. 274:787–789, 1996

    Article  PubMed  Google Scholar 

  52. Wang C. Y., Mayo M. W., Baldwin A. S., Jr.: TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science. 274:784–787, 1996

    Article  PubMed  CAS  Google Scholar 

  53. Gilmore T. D.: Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel. Oncogene. 18:6925–6937, 1999

    Article  PubMed  CAS  Google Scholar 

  54. Neiman P. E., Thomas S. J., Loring G.: Induction of apoptosis during normal and neoplastic B-cell development in the bursa of Fabricius. Proc Natl Acad Sci U S A. 88:5857–5861, 1991

    Article  PubMed  CAS  Google Scholar 

  55. Chu Z. L., McKinsey T. A., Liu L., Gentry J. J., Malim M. H., Ballard D. W.: Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci USA. 94:10057–10062, 1997

    Article  PubMed  CAS  Google Scholar 

  56. Khoshnan A., Tindell C., Laux I., Bae D., Bennett B., Nel A. E.: The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J lmmunol. 165:1743–1754, 2000

    CAS  Google Scholar 

  57. Stehlik C., de Martin R., Kumabashiri I., Schmid J. A., Binder B. R., Lipp J.: Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med. 188:211–216, 1998

    Article  PubMed  CAS  Google Scholar 

  58. Asso-Bonnet M., Feuillard J., Ferreira V., Bissieres P., Tarantino N., Korner M., Raphael M.: Relationship between IkappaBalpha constitutive expression, TNFalpha synthesis, and apoptosis in EBV-infected lymphoblastoid cells. Oncogene. 17:1607–1615, 1998

    Article  PubMed  CAS  Google Scholar 

  59. Lee K. Y., Chang W., Qiu D., Kao P. N., Rosen G. D.: PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells. J Biol Chem. 274:13451–13455, 1999

    Article  PubMed  CAS  Google Scholar 

  60. Sugiyama H., Savill J. S., Kitamura M., Zhao L., Stylianou E.: Selective sensitization to tumor necrosis factor-alpha-induced apoptosis by blockade of NF-kappaB in primary glomerular mesangial cells. J Biol Chem. 274:19532–19537, 1999

    Article  PubMed  CAS  Google Scholar 

  61. Shao R., Karunagaran D., Zhou B. P., Li K., Lo S. S., Deng J., Chiao P., Hung M. C.: Inhibition of nuclear factor-kappaB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis. J Biol Chem. 272:32739–32742, 1997

    Article  PubMed  CAS  Google Scholar 

  62. Kajino S., Suganuma M., Teranishi F., Takahashi N., Tetsuka T., Ohara H., Itoh M., Okamoto T.: Evidence that de novo protein synthesis is dispensable for anti-apoptotic effects of NF-kappaB. Oncogene. 19:2233–2239, 2000

    Article  PubMed  CAS  Google Scholar 

  63. Javelaud D., Besancon F.: NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B. Oncogene. 20:4365–4372, 2001

    Article  PubMed  CAS  Google Scholar 

  64. Bergmann M. W., Loser P., Dietz R., von Harsdorf R.: Effect of NF-kappa B Inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes. J Mol Cell Cardiol. 33:1223–1232, 2001

    Article  PubMed  CAS  Google Scholar 

  65. Li Z. W., Chu W., Hu Y., Delhase M., Deerinck T., Ellisman M., Johnson R., Karin M.: The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med. 189:1839–1845, 1999

    Article  PubMed  CAS  Google Scholar 

  66. Zong W. X., Farrell M., Bash J., Gelinas C.: v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNFalpha-induced cell death. Oncogene. 15:971–980, 1997

    Article  PubMed  CAS  Google Scholar 

  67. Yamit-Hezi A., Dikstein R.: TAFII105 mediates activation of anti-apoptotic genes by NF-kappaB. Embo J. 17:5161–5169, 1998

    Article  PubMed  CAS  Google Scholar 

  68. Shao R., Hu M. C., Zhou B. P., Lin S. Y., Chiao P. J., von Lindern R. H., Spohn B., Hung M. C.: ElA sensitizes cells to tumor necrosis factor-induced apoptosis through inhibition of IkappaB kinases and nuclear factor kappaB activities. J Biol Chem. 274:21495–21498, 1999

    Article  PubMed  CAS  Google Scholar 

  69. Cross J. V., Deak J. C., Rich E. A., Qian Y., Lewis M., Parrott L. A., Mochida K., Gustafson D., Vande Pol S., Templeton D. J.: Quinone reductase inhibitors block SAPK/JNK and NFkappaB pathways and potentiate apoptosis. J Biol Chem. 274:31150–31154, 1999

    Article  PubMed  CAS  Google Scholar 

  70. Foehr E. D., Lin X., O'Mahony A., Geleziunas R., Bradshaw R. A., Greene W. C.: NF-kappa B signaling promotes both cell survival and neurite process formation in nerve growth factor-stimulated PC12 cells. J Neurosci. 20:7556–7563, 2000

    PubMed  CAS  Google Scholar 

  71. Wu M., Lee H., Bellas R. E., Schauer S. L., Arsura M., Katz D., FitzGerald M. J., Rothstein T. L., Sherr D. H., Sonenshein G. E.: Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. Embo J. 15:4682–4690, 1996

    PubMed  CAS  Google Scholar 

  72. Arlt A., Vorndamm J., Breitenbroich M., Folsch U. R., Kalthoff H., Schmidt W. E., Schafer H.: Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncozene. 20:859–868, 2001

    Article  CAS  Google Scholar 

  73. Qin J. Z., Chaturvedi V., Denning M. F., Choubey D., Diaz M. O., Nickoloff B. J.: Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes. J Biol Chem. 274:37957–37964, 1999

    Article  PubMed  CAS  Google Scholar 

  74. Kolenko V., Bloom T., Rayman P., Bukowski R., Hsi E., Finke J.: Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and-3. J Immunol. 163:590–598, 1999

    PubMed  CAS  Google Scholar 

  75. Kawai H., Yamada Y., Tatsuka M., Niwa O., Yamamoto K., Suzuki F.: Down-regulation of nuclear factor kappaB is required for p53-dependent apoptosis in X-ray-irradiated mouse lymphoma cells and thymocytes. Cancer Res. 59:6038–6041, 1999

    PubMed  CAS  Google Scholar 

  76. Aoki M., Nata T., Morishita R., Matsushita H., Nakagami H., Yamamoto K., Yamazaki K., Nakabayashi M., Ogihara T., Kaneda Y.: Endothelial apoptosis induced by oxidative stress through activation of NF-kappaB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension. 38:48–55, 2001

    PubMed  CAS  Google Scholar 

  77. Li Y., Zhang W., Mantell L. L., Kazzaz J. A., Fein A. M., Horowitz S.: Nuclear factor-kappaB is activated by hyperoxia but does not protect from cell death. J Biol Chem. 272:20646–20649, 1997

    Article  PubMed  CAS  Google Scholar 

  78. Ginis I., Hallenbeck J. M., Liu J., Spatz M., Jaiswal R., Shohami E.: Tumor necrosis factor and reactive oxygen species cooperative cytotoxicity is mediated via inhibition of NF-kappaB. Mol Med. 6:1028–1041, 2000

    PubMed  CAS  Google Scholar 

  79. Demarchi F., Verardo R., Varnum B., Brancolini C., Schneider C.: Gas6 anti-apoptotic signaling requires NF-kappa B activation. J Biol Chem. 276:31738–31744, 2001

    Article  PubMed  CAS  Google Scholar 

  80. Zechner D., Craig R., Hanford D. S., McDonough P. M., Sabbadini R. A., Glembotski C. C.: MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J Biol Chem. 273:8232–8239, 1998

    Article  PubMed  CAS  Google Scholar 

  81. Baghdiguian S., Martin M., Richard I., Pons F., Astier C., Bourg N., Hay R. T., Chemaly R., Halaby G., Loiselet J., Anderson L. V., Lopez de Munain A., Fardeau M., Mangeat P., Beckmann J. S., Lefrane G.: Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med. 5:503–511, 1999

    Article  PubMed  CAS  Google Scholar 

  82. Trauzold A., Wermann H., Arlt A., Schutze S., Schafer H., Oestern S., Roder C., Ungefroren H., Lampe E., Heinrich M., Walczak H., Kalthoff H.: CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Oncogene. 20:4258–4269, 2001

    Article  PubMed  CAS  Google Scholar 

  83. Kanai M., Konda Y., Nakajima T., Izumi Y., Takeuchi T., Chiba T.: TGF-alpha inhibits apoptosis of murine gastric pit cells through an NF-kappaB-dependent pathway. Gastroenterology. 121:56–67, 2001

    Article  PubMed  CAS  Google Scholar 

  84. Caamano J., Tato C., Cai G., Villegas E. N., Speirs K., Craig L., Alexander J., Hunter C. A.: Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii. J Immunol. 165:5720–5728, 2000

    PubMed  CAS  Google Scholar 

  85. Wang C. Y., Mayo M. W., Korneluk R. G., Goeddel D. V., Baldwin A. S., Jr.: NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAPI and c-IAP2 to suppress caspase-8 activation. Science. 281:1680–1683, 1998

    Article  PubMed  CAS  Google Scholar 

  86. Manna S. K., Zhang H. J., Yan T., Oberley L. W., Aggarwal B. B.: Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem. 273:13245–13254, 1998

    Article  PubMed  CAS  Google Scholar 

  87. Eichholtz-Wirth H., Sagan D.: IkappaB/NF-kappaB mediated cisplatin resistance in HeLa cells after low-dose gamma-irradiation is associated with altered SODD expression. Apoptosis. 5:255–263, 2000

    Article  PubMed  CAS  Google Scholar 

  88. Bertrand F., Desbois-Mouthon C., Cadoret A., Prunier C., Robin H., Capeau J., Atfi A., Cherqui G.: Insulin antiapoptotic signaling involves insulin activation of the nuclear factor kappaB-dependent survival genes encoding tumor necrosis factor receptor-associated factor 2 and manganese-superoxide dismutase. J Biol Chem. 274:30596–30602, 1999

    Article  PubMed  CAS  Google Scholar 

  89. Krikos A., Laherty C. D., Dixit V. M.: Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J Biol Chem. 267:17971–17976, 1992

    PubMed  CAS  Google Scholar 

  90. Opipari A. W., Jr., Hu H. M., Yabkowitz R., Dixit V. M.: The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem. 267:12424–12427, 1992

    PubMed  CAS  Google Scholar 

  91. Hinz M., Krappmann D., Eichten A., Heder A., Scheidereit C., Strauss M.: NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol. 19:2690–2698, 1999

    PubMed  CAS  Google Scholar 

  92. Guttridge D. C., Albanese C., Reuther J. Y., Pestell R. G., Baldwin A. S., Jr.: NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol. 19:5785–5799, 1999

    PubMed  CAS  Google Scholar 

  93. Wang C. Y., Cusack J. C., Jr., Liu R., Baldwin A. S., Jr.: Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med. 5:412–417, 1999

    Article  PubMed  CAS  Google Scholar 

  94. Zong W. X., Edelstein L. C., Chen C., Bash J., Gelinas C.: The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev. 13:382–387, 1999

    PubMed  CAS  Google Scholar 

  95. de Moissac D., Mustapha S., Greenberg A. H., Kirshenbaum L. A.: Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha. J Biol Chem. 273:23946–23951, 1998

    Article  PubMed  Google Scholar 

  96. Romashkova J. A., Makarov S. S.: NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature. 401:86–90, 1999

    Article  PubMed  CAS  Google Scholar 

  97. Yang C. H., Murti A., Pfeffer S. R., Kim J. G., Donner D. B., Pfeffer L. M.: Interferon alpha /beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt. J Biol Chem. 276:13756–13761, 2001

    PubMed  CAS  Google Scholar 

  98. Natoli G., Costanzo A., Guido F., Moretti F., Bernardo A., Burgio V. L., Agresti C., Levrero M.: Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2. J Biol Chem. 273:31262–31272, 1998

    Article  PubMed  CAS  Google Scholar 

  99. Levkau B., Scatena M., Giachelli C. M., Ross R., Raines E. W.: Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop. Nat Cell Biol. 1:227–233, 1999

    Article  PubMed  CAS  Google Scholar 

  100. Reuther J. Y., Baldwin A. S., Jr.: Apoptosis promotes a caspase-induced amino-terminal truncation of IkappaBalpha that functions as a stable inhibitor of NF-kappaB. J Biol Chem. 274:20664–20670, 1999

    Article  PubMed  CAS  Google Scholar 

  101. Ravi R., Bedi A., Fuchs E. J.: CD95 (Fas)-induced caspase-mediated proteolysis of NF-kappaB. Cancer Res. 58:882–886, 1998

    PubMed  CAS  Google Scholar 

  102. Kitajima I., Soejima Y., Takasaki I., Beppu H., Tokioka T., Maruyama I.: Ceramide-induced nuclear translocation of NF-kappa B is a potential mediator of the apoptotic response to TNF-alpha in murine clonal osteoblasts. Bone. 19:263–270, 1996

    Article  PubMed  CAS  Google Scholar 

  103. Hu X., Tang M., Fisher A. B., Olashaw N., Zuckerman K. S.: TNF-alpha-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation. J Immunol. 163:3106–3115, 1999

    PubMed  CAS  Google Scholar 

  104. Packham G., Lahti J. M., Fee B. E., Gawn J. M., Coustan-Smith E., Campana D., Doughlas I., Kidd V. J., Ghosh S., Cleveland J. L.: Fas activates NF-kB and induces apoptosis in T-cell lines by signaling pathways distinct from those induced by TNF-a. Cell Death Differ. 4:130–139, 1997

    Article  PubMed  CAS  Google Scholar 

  105. Ivanov V. N., Ronai Z.: p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-kappaB activity and Fas expression. Oncojene. 19:3003–3012, 2000

    Article  CAS  Google Scholar 

  106. Dumont A., Hehner S. P., Hofmann T. G., Ueffing M., Droge W., Schmitz M. L.: Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. Oncogene. 18:747–757, 1999

    Article  PubMed  CAS  Google Scholar 

  107. Vollgraf U., Wegner M., Richter-Landsberg C.: Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J Neurochem. 73:2501–2509, 1999

    Article  PubMed  CAS  Google Scholar 

  108. Grey S. T., Arvelo M. B., Hasenkamp W., Bach F. H., Ferran C.: A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J Exp Med. 190:1135–1146, 1999

    Article  PubMed  CAS  Google Scholar 

  109. Bessho R., Matsubara K., Kubota M., Kuwakado K., Hirota H., Wakazono Y., Lin Y. W., Okuda A., Kawai M., Nishikomori R., et al.: Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem Pharmacol. 48:1883–1889, 1994

    Article  PubMed  CAS  Google Scholar 

  110. Stark L. A., Din F. V., Zwacka R. M., Dunlop M. G.: Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. Faseb J. 15:1273–1275, 2001

    PubMed  CAS  Google Scholar 

  111. Gupta R. A., Polk D. B., Krishna U., Israel D. A., Yan F., DuBois R. N., Peek R. M., Jr.: Activation of peroxisome proliferator-activated receptor gamma suppresses nuclear factor kappa B-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells. J Biol Chem. 276:31059–31066, 2001

    Article  PubMed  CAS  Google Scholar 

  112. Lin K. I., Lee S. H., Narayanan R., Baraban J. M., Hardwick J. M., Ratan R. R.: Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J Cell Biol. 131:1149–1161, 1995

    Article  PubMed  CAS  Google Scholar 

  113. Kuhnel F., Zender L., Paul Y., Tietze M. K., Trautwein C., Manns M., Kubicka S.: NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis. J Biol Chem. 275:6421–6427, 2000

    Article  PubMed  CAS  Google Scholar 

  114. Takuma K., Lee E., Kidawara M., Mori K., Kimura Y., Baba A., Matsuda T.: Apoptosis in Ca2 + reperfusion injury of cultured astrocytes: roles of reactive oxygen species and NF-kappaB activation. Eur J Neurosci. 11:4204–4212, 1999

    Article  PubMed  CAS  Google Scholar 

  115. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., Schwaninger M.: NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med. 5:554–559, 1999

    Article  PubMed  CAS  Google Scholar 

  116. Gil J., Alcami J., Esteban M.: Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB. Mol Cell Biol. 19:4653–4663, 1999

    PubMed  CAS  Google Scholar 

  117. Lin K. I., DiDonato J. A., Hoffmann A., Hardwick J. M., Ratan R. R.: Suppression of steady-state, but not stimulus-induced NF-kappaB activity inhibits alphavirus-induced apoptosis. J Cell Biol. 141:1479–1487, 1998

    Article  PubMed  CAS  Google Scholar 

  118. Nakai M., Qin Z. H., Chen J. F., Wang Y., Chase T. N.: Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-kappaB activation. J Neurochem. 74:647–658, 2000

    Article  PubMed  CAS  Google Scholar 

  119. Hettmann T., DiDonato J., Karin M., Leiden J. M.: An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis. J Exp Med. 189:145–158, 1999

    Article  PubMed  CAS  Google Scholar 

  120. Bellas R. E., Sonenshein G. E.: Nuclear factor kappaB cooperates with c-Myc in promoting murine hepatocyte survival in a manner independent of p53 tumor suppressor function. Cell Growth Differ. 10:287–294, 1999

    PubMed  CAS  Google Scholar 

  121. Helenius M., Hanninen M., Lehtinen S. K., Salminen A.: Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kappa B. Biochem J. 318 ( Pt 2):603–608, 1996

    PubMed  CAS  Google Scholar 

  122. Ferran C., Stroka D. M., Badrichani A. Z., Cooper J. T., Wrighton C. J., Soares M., Grey S. T., Bach F. H.: A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood. 91:2249–2258, 1998

    PubMed  CAS  Google Scholar 

  123. Zen K., Karsan A., Stempien-Otero A., Yee E., Tupper J., Li X., Eunson T., Kay M. A., Wilson C. B., Winn R. K., Harlan J. M.: NF-kappaB activation is required for human endothelial survival during exposure to tumor necrosis factor-alpha but not to interleukin-1 beta or lipopolysaccharide. J Biol Chem. 274:28808–28815, 1999

    Article  PubMed  CAS  Google Scholar 

  124. Chen S., Guttridge D. C., Tang E., Shi S., Guan K., Wang C. Y.: Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor kappaB-independent bone morphogenetic protein/Smad signaling. J Biol Chem. 276:39259–39263, 2001

    Article  PubMed  CAS  Google Scholar 

  125. Jiang Y., Woronicz J. D., Liu W., Goeddel D. V.: Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science. 283:543–546, 1999

    Article  PubMed  CAS  Google Scholar 

  126. Okura T., Gong L., Kamitani T., Wada T., Okura I., Wei C. F., Chang H. M., Yeh E. T.: Protection against Fas/APO-1-and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J lmmunol. 157:4277–4281, 1996

    CAS  Google Scholar 

  127. Scaffidi C., Schmitz I., Krammer P. H., Peter M. E.: The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem. 274:1541–1548, 1999

    Article  PubMed  CAS  Google Scholar 

  128. Hall J. L., Wang X., Van A., Zhao Y., Gibbons G. H.: Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappab-independent and-dependent pathways. Circ Res. 88:1247–1253, 2001

    PubMed  CAS  Google Scholar 

  129. Tabata M., Tabata R., Grabowski D. R., Bukowski R. M., Ganapathi M. K., Ganapathi R.: Roles of NF-kappaB and 26 S proteasome in apoptotic cell death induced by topoisomerase I and II poisons in human nonsmall cell lung carcinoma. J Biol Chem. 276:8029–8036, 2001

    Article  PubMed  CAS  Google Scholar 

  130. Herrmann J. L., Beham A. W., Sarkiss M., Chiao P. J., Rands M. T., Bruckheimer E. M., Brisbay S., McDonnell T. J.: Bcl-2 suppresses apoptosis resulting from disruption of the NF-kappa B survival pathway. Exp Cell Res. 237:101–109, 1997

    Article  PubMed  CAS  Google Scholar 

  131. Lallemand F., Mazars A., Prunier C., Bertrand F., Kornprost M., Gallea S., Roman-Roman S., Cherqui G., Atfi A.: Smad7 inhibits the survival nuclear factor kappaB and potentiates apoptosis in epithelial cells. Oncogene. 20:879–884, 2001

    Article  PubMed  CAS  Google Scholar 

  132. Besancon F., Atfi A., Gespach C., Cayre Y. E., Bourgeade M. F.: Evidence for a role of NF-kappaB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor beta fusion protein. Proc Natl Acad Sci USA. 95:8081–8086, 1998

    Article  PubMed  CAS  Google Scholar 

  133. You M., Ku P. T., Hrdlickova R., Bose H. R., Jr.: ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein. Mol Cell Biol. 17:7328–7341, 1997

    PubMed  CAS  Google Scholar 

  134. Oya M., Ohtsubo M., Takayanagi A., Tachibana M., Shimizu N., Murai M.: Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells. Oncogene. 20:3888–3896, 2001

    Article  PubMed  CAS  Google Scholar 

  135. Franek W. R., Horowitz S., Stansberry L., Kazzaz J. A., Koo H. C., Li Y., Arita Y., Davis J. M., Mantell A. S., Scott W., Mantell L. L.: Hyperoxia inhibits oxidant-induced apoptosis in lung epithelial cells. J Biol Chem. 276:569–575, 2001

    Article  PubMed  CAS  Google Scholar 

  136. Hofer-Warbinek R., Schmid J. A., Stehlik C., Binder B. R., Lipp J., de Martin R.: Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J Biol Chem. 275:22064–22068, 2000

    Article  PubMed  CAS  Google Scholar 

  137. Slater A. F., Kimland M., Jiang S. A., Orrenius S.: Constitutive nuclear NF kappa B/rel DNA-binding activity of rat thymocytes is increased by stimuli that promote apoptosis, but not inhibited by pyrrolidine dithiocarbamate. Biochem J. 312 ( Pt 3):833–838, 1995

    PubMed  CAS  Google Scholar 

  138. Ashikawa K., Shishodia S., Fokt I., Priebe W., Aggarwal B. B.: Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues. Biochem Pharmacol. 67:353–364, 2004

    Article  PubMed  CAS  Google Scholar 

  139. Bian X., McAllister-Lucas L. M., Shao F., Schumacher K. R., Feng Z., Porter A. G., Castle V. P., Opipari A. W., Jr.: NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J Biol Chem. 276:48921–48929, 2001

    Article  PubMed  CAS  Google Scholar 

  140. Segev D. L., Ha T. U., Tran T. T., Kenneally M., Harkin P., Jung M., MacLaughlin D. T., Donahoe P. K., Maheswaran S.: Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway. J Biol Chem. 275:28371–28379, 2000

    Article  PubMed  CAS  Google Scholar 

  141. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword Nat Rev Immunol. 2003 Sep; 3(9):745–56.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cytokine Research Section, Department of Experimental Therapeutics, The University of Texas, MD Anderson Cancer Center, Houston, TX

    Bharat B. Aggarwal & Yasunari Takada

Authors
  1. Bharat B. Aggarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasunari Takada
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School, 710 N. Fairbanks Court, Olson 8256, Chicago, IL, 60611, USA

    Leonidas C. Platanias MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Aggarwal, B.B., Takada, Y. (2005). Pro-apototic and Anti-apoptotic Effects of Tumor Necrosis Factor in Tumor Cells. In: Platanias, L.C. (eds) Cytokines and Cancer. Cancer Treatment and Research, vol 126. Springer, Boston, MA. https://doi.org/10.1007/0-387-24361-5_5

Download citation

  • DOI: https://doi.org/10.1007/0-387-24361-5_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-24360-3

  • Online ISBN: 978-0-387-24361-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation